AVEO PHARMACEUTICALS, INC. Quarterly Costs and Expenses in USD from Q1 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Aveo Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2020 to Q3 2022.
  • Aveo Pharmaceuticals, Inc. Costs and Expenses for the quarter ending September 30, 2022 was $32.6M, a 33.7% increase year-over-year.
  • Aveo Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending September 30, 2022 was $119M, a 45.6% increase year-over-year.
  • Aveo Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $91.8M, a 105% increase from 2020.
  • Aveo Pharmaceuticals, Inc. annual Costs and Expenses for 2020 was $44.9M, a 53.9% increase from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $119M $32.6M +$8.23M +33.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $111M $32.5M +$9.84M +43.5% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $101M $29.9M +$8.9M +42.3% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $91.8M $23.8M +$10.2M +75.3% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-14
Q3 2021 $81.6M $24.4M +$12.7M +109% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $68.9M $22.6M +$14.5M +177% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $54.4M $21M +$9.54M +82.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $44.9M $13.6M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $11.7M Jul 1, 2020 Sep 30, 2020 10-K 2022-03-14
Q2 2020 $8.16M Apr 1, 2020 Jun 30, 2020 10-K 2022-03-14
Q1 2020 $11.5M Jan 1, 2020 Mar 31, 2020 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.